FOTIVDA® (tivozanib) Efficacy, Safety, and Use for AdultPatients with Relapsed or Refractory Advanced Renal CellCarcinoma (rrRCC) Following 2 or More Prior SystemicTherapies
June 4, 20265:30 PM CT
Victoria’s7 1st Avenue SWRochester, MN 55902
Presented By: Gail Lowe, RN, AVEO Oncology Nurse Educator
Hosted by: AVEO Oncology Representative Kari Berg at 701-306-3993.
To register, visit: Registration.AveoSB.com and use event code AVON1499.